Answers are grounded in this paper and cite their sources.
Debate over the safety of non-steroidal anti-inflammatory drugs (NSAIDs) in treating covid-19 has continued with the European Medicines Agency saying that the drugs could be considered for treating the emerging viral illness in some cases. The agency’s comments were prompted by claims from France’s health minister Oliver Veran that people showing covid-19 symptoms should use paracetamol rather than ibuprofen, because the latter might worsen the condition.1 The minister’s comments were themselves prompted by reports in French media that the condition of four young people with covid-19 deteriorated after taking ibuprofen. The hospital mentioned in the reports said that it would not comment on such …
No takes yet. Share an insight, caveat, or question.
Michael Day (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: